Fig 1. Expression of TGM2 in high and low tumor-forming MDCK cells detected by real-time PCR and Western blotting.

(A). TGM2 mRNA levels in high and low tumorigenesis MDCK cells determined by real-time PCR. (B). TGM2 protein levels in high and low tumor-forming MDCK cells were determined by Western blotting and densitometrically quantified and normalized to β‐actin (C).